Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

Diagnostic role of endothelial microparticles in vasculitis.

Erdbruegger U, Grossheim M, Hertel B, Wyss K, Kirsch T, Woywodt A, Haller H, Haubitz M.

Rheumatology (Oxford). 2008 Dec;47(12):1820-5. doi: 10.1093/rheumatology/ken373. Epub 2008 Oct 16.

PMID:
18927191
2.

Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement.

Kümpers P, Hellpap J, David S, Horn R, Leitolf H, Haller H, Haubitz M.

Nephrol Dial Transplant. 2009 Jun;24(6):1845-50. doi: 10.1093/ndt/gfn755. Epub 2009 Jan 22.

PMID:
19164323
3.

Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis.

Kümpers P, Horn R, Brabant G, Woywodt A, Schiffer M, Haller H, Haubitz M.

Rheumatology (Oxford). 2008 Apr;47(4):484-7. doi: 10.1093/rheumatology/ken023. Epub 2008 Feb 16.

PMID:
18281689
4.

Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis.

de Groot K, Goldberg C, Bahlmann FH, Woywodt A, Haller H, Fliser D, Haubitz M.

Arthritis Rheum. 2007 Nov;56(11):3847-53.

5.

Endothelial injury and repair in systemic vasculitis of the young.

Clarke LA, Hong Y, Eleftheriou D, Shah V, Arrigoni F, Klein NJ, Brogan PA.

Arthritis Rheum. 2010 Jun;62(6):1770-80. doi: 10.1002/art.27418.

6.

Circulating endothelial microparticles as a marker of cerebrovascular disease.

Jung KH, Chu K, Lee ST, Park HK, Bahn JJ, Kim DH, Kim JH, Kim M, Kun Lee S, Roh JK.

Ann Neurol. 2009 Aug;66(2):191-9. doi: 10.1002/ana.21681.

PMID:
19743467
7.

Elevation of circulating endothelial microparticles in patients with chronic renal failure.

Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F.

J Thromb Haemost. 2006 Mar;4(3):566-73. Epub 2005 Dec 23.

8.

Osteopontin in antineutrophil cytoplasmic autoantibody-associated vasculitis: relation to disease activity, organ manifestation and immunosuppressive therapy.

Lorenzen J, Lovric S, Krämer R, Haller H, Haubitz M.

Ann Rheum Dis. 2010 Jun;69(6):1169-71. doi: 10.1136/ard.2009.113621. Epub 2010 Apr 27.

PMID:
20424002
9.

Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation.

Jimenez JJ, Jy W, Mauro LM, Horstman LL, Soderland C, Ahn YS.

Br J Haematol. 2003 Dec;123(5):896-902.

PMID:
14632781
10.

Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients.

Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ, McGlothlin D, Grossman W, De Marco T, Yeghiazarians Y.

J Heart Lung Transplant. 2009 Oct;28(10):1081-6. doi: 10.1016/j.healun.2009.06.005.

PMID:
19782291
11.

Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis.

Závada J, Kideryová L, Pytlík R, Vanková Z, Tesar V.

Kidney Blood Press Res. 2008;31(4):247-54. doi: 10.1159/000142690. Epub 2008 Jul 4.

12.

Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension.

Diehl P, Aleker M, Helbing T, Sossong V, Germann M, Sorichter S, Bode C, Moser M.

J Thromb Thrombolysis. 2011 Feb;31(2):173-9. doi: 10.1007/s11239-010-0507-z.

PMID:
20680403
13.

Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension.

Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, Grossman W, De Marco T, Yeghiazarians Y.

Am J Respir Crit Care Med. 2008 Jun 1;177(11):1268-75. doi: 10.1164/rccm.200710-1458OC. Epub 2008 Feb 28.

PMID:
18310479
14.

Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis.

Chen M, Wang F, Zhao MH.

Rheumatology (Oxford). 2009 Apr;48(4):355-8. doi: 10.1093/rheumatology/ken500. Epub 2009 Jan 30.

PMID:
19181656
15.

Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility.

Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, He M, Yamada M, Suzuki S, Yanai M, Kurosawa S, Yamaya M, Kubo H.

Thorax. 2012 Dec;67(12):1067-74. doi: 10.1136/thoraxjnl-2011-201395. Epub 2012 Jul 27.

PMID:
22843558
16.

Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome.

Arteaga RB, Chirinos JA, Soriano AO, Jy W, Horstman L, Jimenez JJ, Mendez A, Ferreira A, de Marchena E, Ahn YS.

Am J Cardiol. 2006 Jul 1;98(1):70-4. Epub 2006 May 4.

PMID:
16784924
17.
18.

Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.

Trappenburg MC, van Schilfgaarde M, Marchetti M, Spronk HM, ten Cate H, Leyte A, Terpstra WE, Falanga A.

Haematologica. 2009 Jul;94(7):911-8. doi: 10.3324/haematol.13774. Epub 2009 Jun 8.

19.

Phenotypic assessment of endothelial microparticles in patients with heart failure and after heart transplantation: switch from cell activation to apoptosis.

Garcia S, Chirinos J, Jimenez J, Del Carpio Muñoz F, Canoniero M, Jy W, Jimenez J, Horstman L, Ahn Y.

J Heart Lung Transplant. 2005 Dec;24(12):2184-9. Epub 2005 Nov 2.

PMID:
16364869
20.

Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo.

Abid Hussein MN, Meesters EW, Osmanovic N, Romijn FP, Nieuwland R, Sturk A.

J Thromb Haemost. 2003 Nov;1(11):2434-43.

Supplemental Content

Support Center